Results 21 to 30 of about 92,053 (259)

Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation [PDF]

, 2018
The concentration of ganciclovir eye drops for hospital preparation was changed from 0.5% to 2.0% at the Nagasaki University Hospital from March 2015.
佐々木, 均, 中川, 博雄, 松丸, 由美, 北原, 隆志, 能勢, 誠一   +4 more
core   +1 more source

Improvement of Soft Contact Lens Wettability After the Instillation of Hyaluronic Acid Eye Drops

, 2023
Purpose: To evaluate the effect of the topical instillation of hyaluronic acid eye drops with different viscosity on soft contact lens wettability and comfort.
Martín Gil, Alba, Carracedo Rodríguez, Juan Gonzalo, Carpena Torres, Carlos, Rodríguez Pomar, Candela, Pastrana Robles, Cristina   +4 more
core   +1 more source

Assessing the Impact of Sodium Hyaluronate Eye Drops on the Ocular Surface Microbiome: Implications for Dry Eye Management and Ocular Health : Eye Microbiome

, 2021
: Background: A powerful immunoregulatory function is provided by the ocular surface microbiome, which contributes to ocular pathogenesis, physiological integrity, and pathogenesis of ocular diseases. Using sodium hyaluronate eye drops (with or without a
Kavianfar, Azadeh, Salimi, Mahdieh, Taherkhani, Hamidreza   +2 more
core   +1 more source

Adherence to Eye Drops Usage in Dry Eye Patients and Reasons for Non-Compliance: A Web-Based Survey

, 2022
This study aimed to investigate the actual use of eye drops for dry eye disease (DED), the reasons for instillation behavior, and the relationship between instillation behavior and subjective symptoms.
Miki Uchino, on behalf of the Japan Dry Eye Society on behalf of the Japan Dry Eye Society, Yuichi Hori, Norihiko Yokoi, Kazuo Tsubota, Jun Shimazaki   +5 more
core   +1 more source

Stability Test of PACAP in Eye Drops [PDF]

, 2021
PACAP is a neuropeptide with widespread distribution and diverse biological functions. It has strong cytoprotective effects mediated mainly through specific PAC1 receptors.
Kovács Anita Kármen, Tóth Gábor, Werling Dóra, Reglődi Dóra, Atlasz Tamás, Szabó Edina   +5 more
core   +1 more source

Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration

, 2014
AIMS: To evaluate pazopanib eye drops in patients with subfoveal choroidal neovascularisation secondary to age-related macular degeneration. METHODS: 70 patients with minimally classic or occult subfoveal choroidal neovascularisation were ...
R. Danis, for the Pazopanib Eye Drops Study Group, C. Xu, R. Y. Kim, G. Staurenghi, M. Tolentino, M. W. Johnson, M. M. McLaughlin, L. Ye   +8 more
core   +1 more source

Selenium compound protects corneal epithelium against oxidative stress. [PDF]

PLoS ONE, 2012
The ocular surface is strongly affected by oxidative stress, and anti-oxidative systems are maintained in corneal epithelial cells and tear fluid. Dry eye is recognized as an oxidative stress-induced disease.
Akihiro Higuchi, Hiroyoshi Inoue, Tetsuya Kawakita, Tadashi Ogishima, Kazuo Tsubota   +4 more
doaj   +1 more source

Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye

Pharmaceutics, 2022
Eye drops are the most common and convenient route of topical administration and the first choice of treatment for many ocular diseases. However, the ocular bioavailability of traditional eye drops (i.e., solutions, suspensions, and ointments) is very ...
Yaru Wang, Changhong Wang
doaj   +1 more source

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis

Ophthalmology and Therapy, 2019
Introduction Treatment of the anterior segment problems in cystinosis is challenging as oral cysteamine is ineffective in the treatment of corneal problems because of its avascular structure.
Freya Peeters, Catherine Cassiman, Karel Van Keer, Elena Levtchenko, Koenraad Veys, Ingele Casteels   +5 more
doaj   +1 more source

In search of disambiguation: development of eye drop bottle sleeves to aid in identification and survey among possible users. A cross-sectional study

São Paulo Medical Journal
BACKGROUND: Considerable numbers of individuals present low vision, blindness, illiteracy and other conditions that could possibly impair their identification of medications, such as eye drops.
Ana Luiza Fontes de Azevedo Costa, Thiago Gonçalves dos Santos Martins, Vagner Rogério dos Santos, Paulo Schor   +3 more
doaj   +1 more source